PerkinElmer Integrates Electronic Laboratory Notebook (ELN) with Elsevier’s Reaxys® Chemistry Workflow Solution
Article Sep 20, 2012
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, has announced that its electronic laboratory notebook (ELN) can now be seamlessly integrated with Elsevier’s Reaxys®, a web-based workflow solution designed for chemistry researchers in drug discovery, chemicals and academic research.
“As chemists are increasingly turning to electronic laboratory notebooks to plan, execute and record their experiments, they also need ready access to complementary tools and data sources directly within the ELN interface.” said Michael Stapleton, general manager, PerkinElmer Informatics, “The interoperability of our ELN and Elsevier’s Reaxys provides researchers with access to extensive information on chemical compounds and related physical and pharmacological properties so that they can make better decisions. This integration also allows researchers to save valuable time by providing the ability to rapidly search and import external data while eliminating transcription errors.”
Capturing Reaxys content through PerkinElmer’s ELN gives researchers the power to simultaneously leverage information from both sources in order to make critical decisions throughout the chemistry research workflow. Chemical searches in Reaxys can be initiated in an experimental section in the ELN, based on existing or newly drawn compounds or reactions, and results are immediately available. Once suitable reactions are located and selected in Reaxys, they can be exported directly to the ELN and inserted into a pre-designed experiment, complete with reaction scheme, stoichimetry table and preparation text.
PerkinElmer and Elsevier will host an informative workshop at the American Chemical Society in Philadelphia, PA on August 20th at 8:30 am EST to demonstrate and discuss the benefits of integrating Reaxys and PerkinElmer’s ELN. To register for the workshop, signup here.
Integrating the ELN with Reaxys is available at no extra charge to customers who already have both systems.
Advancing Drug Discovery Through Academic–Industry CollaborationArticle
Genestack recently announced that they were joining the Milner Therapeutics Institute. In light of the announcement, I spoke to Prof. Tony Kouzarides, Director of the Milner Therapeutics Institute and Dr. Misha Kapushesky, Founder and CEO of Genestack, to learn more.READ MORE
The Lab of the Future: Artificial Intelligence, Machine Learning, and MicrofluidicsArticle
Today’s laboratories look very different to ten years ago, but what about ten years from now? When it comes to laboratory evolution, great strides have been made over the past decade, and further technological advancements are sure to bring us even closer to a fully automated ‘intelligent lab of the future’.READ MORE
Artificial Intelligence and Machine Learning Have Taken Centre Stage – Here’s WhyArticle
We’ve reached a significant point in time where the interest in Artificial Intelligence (AI), machine learning and deep learning have gained huge amounts of traction - why? We are moving into an era where science fiction is now becoming fact and reality.READ MORE